Skip to content

Research of gastric juice metabolomics in patients with bile reflux gastritis and gastric cancer

Research of gastric juice metabolomics in patients with bile reflux gastritis and gastric cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035004
Enrollment
Unknown
Registered
2020-07-27
Start date
2020-08-10
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bile reflux gastritis and gastric cancer

Interventions

bile reflux gastritis:Nil
gastric cancer:Nil

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Chinese. 2. Those who have bile-like turbidity in the mucus lake of the fundus of the stomach under gastroscope or diagnosed as gastric adenocarcinoma by histology or cytology. 3. No other acute or chronic diseases. 4. Aged 18-75 years. 5. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who have gastroesophageal reflux disease. 2. Those who hvae acute and chronic digestive tract diseases such as digestrive ulcer. 3. Those who have other cancers. 4. Those who used antibiotics during the illness or within four weeks before the study. 5. Those who routinely take prescription Chinese and Western medicines. 6. Women who are pregnant or breastfeeding. 7. Those who have been judged by the attending physician to be unable or unsuitable for gastroscopy. 8. Those who are participating in or have participated in other clinical research four weeks before the start of this study.

Design outcomes

Primary

MeasureTime frame
metabolomic profile of bile acid in gastric juice;

Countries

China

Contacts

Public ContactAihua Zhao

Shanghai Sixth People's Hospital

zhah@sjtu.edu.cn+86 021-24056374

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026